Publication of the French decree regarding the experimentation of the “direct access” to pharmaceutical products with anticipated reimbursement: a half-hearted step forward for pharmaceutical innovations…. By: Hogan Lovells
Previous Story
The UK’s Proposed Laws to Tackle Consumer Subscription Traps – 5 Things You Need to Know
Next Story
Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy
